Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Cyclosporine vs Dexamethasone for Vernal Keratoconjunctivitis in Rwanda
NCT01211327Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jul 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in Vernal Keratoconjunctivitis (VKC), sponsored by Ghent University Hospital. Started Jul 2008; status: completed.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT01211327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211327.